CytaCoat AB
PrivateLast Round
VC Round
Apr 29, 2021
Total Funding Raised
$663,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CytaCoat AB operates in Healthcare & Life Sciences and is based in Solna. Its latest recorded funding round was a VC Round in April 2021.
CytaCoat AB is a biotechnology company that develops a unique anti-fouling and anti-biofilm coating for medical devices to prevent Healthcare Associated Infections (HAIs).
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytaCoat AB Comparables
Compare CytaCoat AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LipoCoat | 85% | |
| BioInteractions | 81% | |
| SPARTHA Medical | 78% |
For institutional investors. Book with your work email.
CytaCoat AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 29, 2021 | ||||
| Grant | Jun 1, 2019 | ||||
| Grant | Dec 1, 2017 | ||||
| Grant | Jun 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CytaCoat AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vinnova | Grant |
| Segulah Medical Acceleration | VC Round |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 119% MoM, reaching 2K.
- Apr 29, 2021
Led by Segulah Medical Acceleration
For institutional investors. Book with your work email.
CytaCoat AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CytaCoat AB's valuation, stock price, and market status.
Is CytaCoat AB a public or private company?
CytaCoat AB is a private company.
What is the current stock price of CytaCoat AB?
CytaCoat AB is a private company, so its shares have no public market price. Caplight tracks CytaCoat AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CytaCoat AB worth (valuation)?
Valuation information for CytaCoat AB is not publicly available.
Can I buy CytaCoat AB stock?
CytaCoat AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CytaCoat AB's last funding round?
CytaCoat AB's most recent funding round was VC Round on April 29, 2021.
Who are the main investors in CytaCoat AB?
Key investors in CytaCoat AB include Segulah Medical Acceleration.
Will CytaCoat AB IPO soon?
No public IPO plans have been announced for CytaCoat AB.
How can I track CytaCoat AB secondary market activity?
Caplight tracks bids, offers, and trades in CytaCoat AB's shares on secondary markets.